Analysts Anticipate Encompass Health Corp (NYSE:EHC) to Announce $0.97 Earnings Per Share

Equities analysts expect Encompass Health Corp (NYSE:EHC) to post earnings per share of $0.97 for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Encompass Health’s earnings, with estimates ranging from $0.95 to $1.00. Encompass Health posted earnings of $0.99 per share during the same quarter last year, which would suggest a negative year over year growth rate of 2%. The company is scheduled to report its next quarterly earnings results after the market closes on Monday, July 29th.

On average, analysts expect that Encompass Health will report full year earnings of $3.80 per share for the current year, with EPS estimates ranging from $3.75 to $3.88. For the next financial year, analysts expect that the company will post earnings of $3.84 per share, with EPS estimates ranging from $3.57 to $4.00. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of analysts that follow Encompass Health.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Thursday, April 25th. The company reported $1.04 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.89 by $0.15. Encompass Health had a return on equity of 23.82% and a net margin of 7.14%. The company had revenue of $1.12 billion for the quarter, compared to the consensus estimate of $1.11 billion.

Several equities research analysts have weighed in on the company. Barclays upgraded Encompass Health from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $68.00 to $70.00 in a report on Thursday, May 30th. BMO Capital Markets began coverage on Encompass Health in a research report on Thursday, June 27th. They set an “outperform” rating and a $72.00 price objective for the company. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $78.00.

NYSE EHC traded up $0.11 during trading hours on Friday, hitting $65.51. 928,975 shares of the company were exchanged, compared to its average volume of 683,841. The company’s 50 day simple moving average is $62.01. The company has a debt-to-equity ratio of 1.71, a quick ratio of 0.89 and a current ratio of 0.89. Encompass Health has a 52-week low of $56.74 and a 52-week high of $82.46. The firm has a market capitalization of $6.48 billion, a price-to-earnings ratio of 18.05, a price-to-earnings-growth ratio of 2.20 and a beta of 0.81.

The firm also recently disclosed a quarterly dividend, which was paid on Monday, July 15th. Stockholders of record on Monday, July 1st were given a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, June 28th. This represents a $1.08 annualized dividend and a dividend yield of 1.65%. Encompass Health’s dividend payout ratio is currently 29.75%.

Encompass Health Company Profile

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Further Reading: Preferred Stock

Get a free copy of the Zacks research report on Encompass Health (EHC)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with's FREE daily email newsletter.